Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV
NCT ID: NCT03296202
Last Updated: 2025-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
7200 participants
OBSERVATIONAL
2017-07-18
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objective of the cohort is to describe and study the evolution of HIV infection in ART-treated individuals.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evolution of the Clinical, Immuno-virological and Aging Trajectory of Patients Living With HIV
NCT06258122
Long-term Follow-up of HIV Infected Patients Identified During Early Infection
NCT00086372
Variation in Drug Interactions in People With HIV (PLWH) Aged 60 Years and Older.
NCT06717581
Older HIV-infected Adults and Drug Interactions: French Cross-sectional Study
NCT03416881
Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population
NCT00796146
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Moreover, the global evaluation of health in PLHIV, including psychiatric, neurologic and social determinants and not only biomedical determinants represents one of the public health challenges of the next decade in the field of HIV infection.
The aim of the present study is to study the emerging morbidity occurring during the course of HIV infection in people treated with ART as well as to describe the tolerance and efficacy of new available ART regimens.
The follow-up of patients will be performed according to national guidelines. Demographic, clinical, biological and therapeutic data will be captured at each patient's hospital contact according to a standardized questionnaire.
All events occurring during the course of clinical management will be prospectively registered in the database according to the ICD 10th revision. A biobank will be collected from every consenting PLHIV at inclusion in the cohort and then every two years.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HIV patients
7200 patients infected with HIV-1
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Confirmed HIV infection
* Signed informed consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Agency for Research on AIDS and Viral Hepatitis (ANRS)
OTHER
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
French Ministry of Health through the COREVIH Aquitaine
UNKNOWN
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Linda WITTKOP, MD, PhD
Role: STUDY_CHAIR
ISPED - CHU de Bordeaux
Fabrice BONNET, Prof
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Bordeaux
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
service de médecine interne - CH d'Agen
Agen, , France
Médecine interne - CH d'Angoulême
Angoulême, , France
service de maladies infectieuses - CH de la Côte Basque
Bayonne, , France
service de médecine inter et maladies infectieuses - Hopital Saint André
Bordeaux, , France
service de médecine interne et maladies infectieuses - Hôpital Saint-André
Bordeaux, , France
service de maladies infectieuses et médecine tropicale - Hôpital Pellegrin
Bordeaux, , France
service de maladies infectieuses et médecine tropicale - Hôpital Pellegrin
Bordeaux, , France
service de maladies infectieuses et médecine tropicale - Hôpital Pellegrin
Bordeaux, , France
Service D'Urgences Pédiatriques
Bordeaux, , France
médecine interne - CH de Châtellerault
Châtellerault, , France
service de médecine interne et maladies infectieuses - CH de Dax
Dax, , France
Médecine Interne - CH de Jonzac
Jonzac, , France
service de médecine interne - CH d'Arcachon
La Teste-de-Buch, , France
service de médecine interne - CH de Libourne
Libourne, , France
service de médecine interne - CH de Mont de Marsan
Mont-de-Marsan, , France
service de médecine interne - CH d'Orthez
Orthez, , France
service de médecine interne et maladies infectieuses - CH de Pau
Pau, , France
service de médecine interne et maladies infectieuses - Groupe hospitalier Sud
Pessac, , France
service de médecine interne et maladies infectieuses - CH de Périgueux
Périgueux, , France
Médecine interne et Maladies Infectieuses - CHU de Poitiers
Poitiers, , France
Médecine interne - CH de Royan
Royan, , France
Médecine Interne - CH de Saint-Jean-D'Angely
Saint-Jean-d'Angély, , France
Médecine Interne - CH de Saintonge
Saintes, , France
service de maladies infecteieuses - CH Saint-Cyr
Villeneuve-sur-Lot, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Devos S, Bonnet F, Hessamfar M, Neau D, Vareil MO, Leleux O, Cazanave C, Rouanes N, Duffau P, Lazaro E, Dabis F, Wittkop L, Barger D; ANRS CO3-AQUIVIH-NA-QuAliV. Tobacco, alcohol, cannabis, and illicit drug use and their association with CD4/CD8 cell count ratio in people with controlled HIV: a cross-sectional study (ANRS CO3 AQUIVIH-NA-QuAliV). BMC Infect Dis. 2023 Jan 9;23(1):16. doi: 10.1186/s12879-022-07963-6.
Barger D, Hessamfar M, Neau D, Vareil MO, Lazaro E, Duffau P, Rouanes N, Leleux O, Le Marec F, Erramouspe M, Wittkop L, Dabis F, Bonnet F. Assessing the psychometric properties of the French WHOQOL-HIV BREF within the ANRS CO3 Aquitaine Cohort's QuAliV ancillary study. Health Qual Life Outcomes. 2020 Jul 10;18(1):220. doi: 10.1186/s12955-020-01451-8.
Barger D, Leleux O, Conte V, Sapparrart V, Gapillout M, Crespel I, Erramouspe M, Delveaux S, Wittkop L, Dabis F, Bonnet F. Web-Based Module for the Collection of Electronic Patient-Reported Outcomes in People Living With HIV in Nouvelle Aquitaine, France: Usability Evaluation. JMIR Form Res. 2019 Dec 18;3(4):e15013. doi: 10.2196/15013.
Barger D, Leleux O, Conte V, Sapparrart V, Gapillout M, Crespel I, Erramouspe M, Delveaux S, Dabis F, Bonnet F. Integrating Electronic Patient-Reported Outcome Measures into Routine HIV Care and the ANRS CO3 Aquitaine Cohort's Data Capture and Visualization System (QuAliV): Protocol for a Formative Research Study. JMIR Res Protoc. 2018 Jun 7;7(6):e147. doi: 10.2196/resprot.9439.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUBX 2016/04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.